801-2, Jindong Mansion, No. 536 Xueshi Road, Yinzhou, Ningbo 315100, P.R.China
Home ProductsSmall Volume Parenteral

Metoclopramide Hydrochloride Small Volume Parenteral Intramuscular Administration

Metoclopramide Hydrochloride Small Volume Parenteral Intramuscular Administration

Metoclopramide Hydrochloride Small Volume Parenteral Intramuscular Administration

Product Details:

Place of Origin: China
Brand Name: Newlystar
Certification: GMP
Model Number: 10mg:2ml

Payment & Shipping Terms:

Minimum Order Quantity: 500, 000 amps
Price: Negotiation
Packaging Details: 10 x 10amps/box
Delivery Time: 45days
Payment Terms: L/C, T/T
Supply Ability: one million amps per day
Contact Now
Detailed Product Description
Product: Metoclopramide Hydrochloride Injection Specification: 10mg:2ml
Standard: BP, USP Packing: 10 X 10amps/box

Metoclopramide Hydrochloride Small Volume Parenteral Intramuscular Administration

 

 

Product : Metoclopramide Hydrochloride Injection

Specification : 10mg:2ml

Standard : BP, USP

Packing : 10 x 10amps/box

 

Description :

Metoclopramide hydrochloride is a white crystalline, odorless substance, freely soluble in water. Chemically,

Metoclopramide Injection, USP is a clear, colorless, sterile solution with a pH of 2.5 to 6.5 for intravenous (IV) or intramuscular (IM) administration.

This product is light sensitive. It should be inspected before use and discarded if either color or particulate is observed.

 

Indication

For the treatment of gastroesophageal reflux disease (GERD). It is also used in treating nausea and vomiting, and to increase gastric emptying.

 

Pharmacodynamics

Metoclopramide, although chemically related to procainamide, does not possess local anesthetic or antiarrhythmic properties. Metoclopramide is used to enhance GI motility, to treat diabetic gastroparesis, as an antinauseant, and to facilitate intubation of the small bowel during radiologic examination. Metoclopramide may be used to treat chemotherapy-induced emesis and as a radiosensitizing agents in the treatment of non-small cell lung carcinoma and glioblastomas in the future.

 

Mechanism of action

Metoclopramide inhibits gastric smooth muscle relaxation produced by dopamine, therefore increasing cholinergic response of the gastrointestinal smooth muscle. It accelerates intestinal transit and gastric emptying by preventing relaxation of gastric body and increasing the phasic activity of antrum. Simultaneously, this action is accompanied by relaxation of the upper small intestine, resulting in an improved coordination between the body and antrum of the stomach and the upper small intestine. Metoclopramide also decreases reflux into the esophagus by increasing the resting pressure of the lower esophageal sphincter and improves acid clearance from the esophagus by increasing amplitude of esophageal peristaltic contractions. Metoclopramide's dopamine antagonist action raises the threshold of activity in the chemoreceptor trigger zone and decreases the input from afferent visceral nerves. Studies have also shown that high doses of metoclopramide can antagonize 5-hydroxytryptamine (5-HT) receptors in the peripheral nervous system in animals.

Contact Details
Newlystar (Ningbo) Medtech Co.,Ltd.

Contact Person: Luke Liu

Send your inquiry directly to us (0 / 3000)

Other Products